نتایج جستجو برای: β lactamase inhibitor

تعداد نتایج: 387791  

Journal: :Journal of clinical microbiology 2012
Fu-Chen Yang Jing-Jou Yan Kuei-Hsiang Hung Jiunn-Jong Wu

The emergence of carbapenem resistance in Enterobacteriaceae has become a great concern. The aim of this study was to characterize ertapenem-resistant Enterobacter cloacae isolates from a Taiwanese university hospital. A total of 355 nonduplicated E. cloacae isolates collected in 2007 were analyzed by antimicrobial susceptibility testing with and without an inhibitor of efflux pumps and AmpC β-...

Journal: :Open Forum Infectious Diseases 2022

Abstract Background Meropenem-vaborbactam (MV) is the first carbapenem/β-lactamase inhibitor combination developed to restore meropenem susceptibility against KPC-producing carbapenem-resistant Enterobacterales(CRE). Vaborbactam (VAB) potently inhibits Ambler class A and C β-lactamases by reversible covalent binding of boronate serine side chains β-lactamases. Resistance MV in non-metallo-β-lac...

Journal: : 2022

Objective. To determine whether the genes whose products are annotated as «MBL-fold metallohydrolase superfamily» related to proteins of metallo-β-lactamase group. Materials and Methods. Sequences 7 were analyzed using following resources: ClustalW, IQ-TREE, iTOL. Selection oligonucleotides for real-time PCR was performed Primer-BLAST resource. The level gene expression assessed PCR. MIC MBC me...

Journal: :Antimicrobial agents and chemotherapy 2015
Premavathy Levasseur Anne-Marie Girard Christine Miossec John Pace Ken Coleman

The novel β-lactamase inhibitor avibactam is a potent inhibitor of class A, class C, and some class D enzymes. The in vitro antibacterial activity of the ceftazidime-avibactam combination was determined for a collection of Enterobacteriaceae clinical isolates; this collection was enriched for resistant strains, including strains with characterized serine β-lactamases. The inhibitor was added ei...

Masood Heydarifar, Pegah Shakib, Rashid Ramazanzadeh, Samaneh Rouhi,

Staphylococcus aureus is a common cause of hospital-acquired infections. This bacterium is resistant to β-lactam antibiotics. The aim of this study was to evaluate the prevalence of S. aureus strains producing enzymes capable of destroying β-lactam antibiotics in a hospital environment. This descriptive and analytic study was performed in Besat Hospital, Sanandaj, Iran, 2016, on 158 swabs colle...

2012
Varsha Gupta Karthikeyan Kumarasamy Neelam Gulati Ritu Garg Padma Krishnan Jagdish Chander

BACKGROUND & OBJECTIVES AmpC β-lactamases are clinically significant since these confer resistance to cephalosporins in the oxyimino group, 7-α methoxycephalosporins and are not affected by available β-lactamase inhibitors. In this study we looked for both extended spectrum β-lactamases (ESBL) and AmpC β-lactamases in Klebsiella pneumoniae clinical isolates. METHODS One hundred consecutive, n...

Journal: :The Journal of antimicrobial chemotherapy 2014
Viveka Schaar Ida Uddbäck Therese Nordström Kristian Riesbeck

OBJECTIVES Group A streptococci (GAS) cause, among other infections, pharyngotonsillitis in children. The species is frequently localized with the Gram-negative respiratory pathogens non-typeable Haemophilus influenzae (NTHi) and Moraxella catarrhalis, which both produce outer membrane vesicles (OMVs). The aim of this study was to investigate whether OMVs isolated from NTHi contain functional β...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید